Halozyme Therapeutics, Inc. (BIT:1HALO)
49.94
0.00 (0.00%)
At close: Aug 6, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Revenue Under Collaborative Agreements | 140.84M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue Under Collaborative Agreements Growth | 75.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalties | 570.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalties Growth | 45.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Proprietary Products | 166.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Proprietary Products Growth | 13.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Bulk rHuPH20 | 86.33M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Bulk rHuPH20 Growth | 0.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Device Partnered Products | 50.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales of Device Partnered Products Growth | 3.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 9.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 690.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland | 212.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 18.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ireland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ireland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other Foreign Countries Revenue (Pre-FY2023) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other Foreign Countries Revenue (Pre-FY2023) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Belgium | 84.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Belgium Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 9.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|